Epkinly Injection, Solution
Product Images NDC 82705-002

3 FDA label images from Genmab Us, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Epkinly (NDC 82705-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genmab Us, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Epkinly 01)

Figure 1 (Epkinly 01)
A Kaplan-Meier survival probability graph comparing treatment with Lenalidomide and Rituximab versus EPKINLY (epcoritamab-bysp) combined with Lenalidomide and Rituximab over 24 months since randomization. The chart includes censored data points and a table showing the number of subjects at risk at various time intervals for each treatment group.*
FDA Label Image

Principal Display Panel (48 mg/0.8 mL Vial Carton)

Principal Display Panel (48 mg/0.8 mL Vial Carton)
EPKINLY (epcoritamab-bysp) Injection 48 mg/0.8 mL single-dose vial label. The label indicates subcutaneous injection for administration by a healthcare provider only. It includes instructions to provide the enclosed Medication Guide to the patient and to discard any unused portion. The label also displays the NDC 82705-010-01 and the manufacturers Genmab and Abbvie logos.*
FDA Label Image

Principal Display Panel (4 mg/0.8 mL Vial Carton)

Principal Display Panel (4 mg/0.8 mL Vial Carton)
EPKINLY (epcoritamab-bysp) Injection 4 mg/0.8 mL subcutaneous solution in a single-dose vial. Label indicates use by a healthcare provider and discard of unused portion. Labeler: Genmab US, Inc., in collaboration with AbbVie.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.